Donor Stem Cell Transplant in Treating Patients With Relapsed Hematologic Cancer - Related Studies - ClinicalTrials.gov

Skip to Main Content

ClinicalTrials.gov

Home Search Study Topics Glossary


	Full Text View


	Tabular View


	No Study Results Posted


	Related Studies

Donor Stem Cell Transplant in Treating Patients With Relapsed Hematologic Cancer

This study is ongoing, but not recruiting participants.

Study NCT00053196 Information provided by National Cancer Institute (NCI)

First Received: January 27, 2003 Last Updated: February 6, 2009 History of Changes

Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:

Conditions listed in this trial

Leukemia
Lymphoma
Myelodysplastic Syndromes

Additional conditions recognized in this trial

Multiple Myeloma
Myelodysplastic-Myeloproliferative Diseases
Myeloproliferative Disorders
Neoplasms
Neoplasms, Plasma Cell
Preleukemia
Syndrome

More general conditions related to this trial

Blood Protein Disorders
Bone Marrow Diseases
Cardiovascular Diseases
Disease
Hematologic Diseases
Hemorrhagic Disorders
Hemostatic Disorders
Immune System Diseases
Immunoproliferative Disorders
Lymphatic Diseases
Lymphoproliferative Disorders
Neoplasms by Histologic Type
Paraproteinemias
Pathologic Processes
Precancerous Conditions
Vascular Diseases

Interventions listed in this trial

anti-thymocyte globulin
filgrastim
therapeutic allogeneic lymphocytes
busulfan
fludarabine phosphate
methotrexate
mycophenolate mofetil
tacrolimus

Additional drug interventions recognized in this trial

Antilymphocyte Serum
Fludarabine
Fludarabine monophosphate
Mycophenolic Acid
Vidarabine

Sponsors listed in this trial

Cancer and Leukemia Group B
National Cancer Institute (NCI)

Back to top of Main Content